NYSE: WSTWest Pharmaceutical Services Revenue
West Pharmaceutical Services revenue was $3.02B for the trailing 12 months ending Sep 30, 2025, with -0.3% growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $804.6M, up 5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, WST annual revenue was $2.9B, with -1.9% growth year-over-year.
WST past revenue growth
How has WST's revenue growth performed historically?
Company
4.92%
Industry
13.71%
Market
22.17%
WST's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
WST's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
WST's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
WST revenue history
Current Revenue
$3.0B
Current Earnings
$491.7M
Current Profit Margin
16.3%
WST's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when WST announces revenue.
WST Revenue History By Year
| WST Yearly Revenue | WST Revenue | WST Change | WST Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $2.89B | -$56.60M | -1.92% |
| 2023-12-31 | $2.95B | $62.90M | +2.18% |
| 2022-12-31 | $2.89B | $55.30M | +1.95% |
| 2021-12-31 | $2.83B | $684.70M | +31.89% |
| 2020-12-31 | $2.15B | $307.00M | +16.69% |
| 2019-12-31 | $1.84B | $122.50M | +7.13% |
| 2018-12-31 | $1.72B | $118.30M | +7.40% |
| 2017-12-31 | $1.60B | $90.00M | +5.96% |
| 2016-12-31 | $1.51B | $109.30M | +7.81% |
| 2015-12-31 | $1.40B | -$21.60M | -1.52% |
| 2014-12-31 | $1.42B | $53.00M | +3.87% |
| 2013-12-31 | $1.37B | $102.00M | +8.05% |
| 2012-12-31 | $1.27B | $74.10M | +6.21% |
| 2011-12-31 | $1.19B | $87.60M | +7.93% |
| 2010-12-31 | $1.10B | $49.00M | +4.64% |
| 2009-12-31 | $1.06B | $4.60M | +0.44% |
| 2008-12-31 | $1.05B | $31.00M | +3.04% |
| 2007-12-31 | $1.02B | $106.80M | +11.69% |
| 2006-12-31 | $913.30M | $213.60M | +30.53% |
| 2005-12-31 | $699.70M | $158.10M | +29.19% |
| 2004-12-31 | $541.60M | $58.20M | +12.04% |
| 2003-12-31 | $483.40M | $70.60M | +17.10% |
| 2002-12-31 | $412.80M | $20.50M | +5.23% |
| 2001-12-31 | $392.30M | $19.80M | +5.32% |
| 2000-12-31 | $372.50M | -$23.30M | -5.89% |
| 1999-12-31 | $395.80M | -$53.90M | -11.99% |
| 1998-12-31 | $449.70M | -$2.80M | -0.62% |
| 1997-12-31 | $452.50M | -$6.30M | -1.37% |
| 1996-12-31 | $458.80M | $45.90M | +11.12% |
| 1995-12-31 | $412.90M | $47.80M | +13.09% |
| 1994-12-31 | $365.10M | $16.40M | +4.70% |
| 1993-12-31 | $348.70M | $10.50M | +3.10% |
| 1992-12-31 | $338.20M | N/A | N/A |
West Pharmaceutical Services Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.